Inogen (INGN) Cash & Equivalents Growth (3y) (2015 - 2026)
Powered by 
Analysis
Inogen (INGN) Cash & Equivalents Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 32.23% |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | -19.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.56% |
| Mar 31, 2026 | -17.22% |
| Dec 31, 2025 | -17.84% |
| Sep 30, 2025 | -20.21% |
| Jun 30, 2025 | -22.60% |
| Mar 31, 2025 | -17.71% |
| Dec 31, 2024 | -20.71% |
| Sep 30, 2024 | -24.09% |
| Jun 30, 2024 | -25.71% |
| Mar 31, 2024 | -21.25% |
| Dec 31, 2023 | -16.03% |
| Sep 30, 2023 | -16.49% |
| Jun 30, 2023 | -7.82% |
| Mar 31, 2023 | -7.64% |
| Dec 31, 2022 | -1.89% |
| Sep 30, 2022 | 10.32% |
| Jun 30, 2022 | 1.49% |
| Mar 31, 2022 | 3.90% |
| Dec 31, 2021 | 6.20% |
| Sep 30, 2021 | 11.07% |